Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma.
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma. Ann N Y Acad Sci. 2013 Jul; 1291:1-13.
View in:
PubMed
subject areas
Animals
Antibodies, Monoclonal
Antineoplastic Agents
Clinical Trials as Topic
Humans
Immunotherapy
Melanoma
Skin Neoplasms
Survival Rate
Treatment Outcome
authors with profiles
Frank Stephen Hodi, M.D.